Company
United StatesPublic company, NYSE: MCKMcKesson (NYSE: MCK), Irving, TX – FDA Inspections
Inspection records and compliance data for McKesson in Irving, Texas. 1 FDA inspection on record, last inspected February 27, 2024. Publicly traded as NYSE: MCK.
Company Profile
This profile covers McKesson based in Irving, Texas, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected February 27, 2024.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 27, 2024 | NAI | Human Drugs · Drug Quality Assurance | 1232064 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
McKesson
Stock ticker
MCK
Exchange
NYSE
Share price
$1,077.29
Market cap
$124.4B
Price as of
November 6, 2026
FEI Number
3013391744
Address
6555 State Highway 161, Irving, Texas 75039, United States
Country
United States
ID: 0f222c3b-df60-44d8-89ea-82f2d7ee4ff2